C-HS5FLuca Science
mitochondria transfer, drug delivery, formulation
replacementreplacingorganelle transplantation
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-HS5F
C-HS5FC-HS5Fmitochondria transfer, drug delivery, formulation
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Luca Science mitochondria transfer, drug delivery, formulation
LUCA Science is a pre-clinical stage biotechnology company focused on developing functional mitochondria as therapeutic agents. The company says it has developed a proprietary method to isolate functional mitochondria and combines this with drug delivery and formulation technology so mitochondria can be stored and delivered as biopharmaceutical agents. Its site highlights potential applications in damaged tissues and organs and inherited mitochondrial diseases.
The published score reflects a curated read of public evidence across 16 dimensions. Each dimension below shows the rationale we used. Disagree with a reading? Tell us where we are wrong →
Higher up = higher Eternal Search score. Further right = closer to achieving real longevity outcomes (early mechanism → translational → near-term readout). Bubble size = capital deployed. Watch for MISMATCHES: big bubbles on the left are well-capitalized but far from goals; small bubbles on the right are doing more with less.
Luca Science — Early mechanism · Lower middle. Derived deterministically from 5 extracted project(s). Most-advanced status: preclinical. Band: early_mechanism. Modifiers: +5 depth (4 programs at preclinical).…
Source: Deterministic